Assay for in vitro measurement of amino-telopeptides of type 1 collagen
CA 1340523 C · Owner: Washington Research Foundation · Inventors: Eyre, David R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of determining type I collagen degradation in vivo are provided by determining the presence or concentration of a peptide in a body fluid the peptide being an N-terminal type I collagen telopeptide fragment containing a hydroxylysyl pyridinoline or lysyl pyridinoline cross-link. Kits comprising an immunological binding partner which binds to a type I collagen telopeptide fragmentused to assay these peptides in a body fluid are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 4, 1999. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 4, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.